These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 23692473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing.
    Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C.
    Transfusion; 2012 Mar; 52(3):493-502. PubMed ID: 21883262
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stability of ex vivo coagulation factor activity in never-frozen and thawed refrigerated canine plasma stored for 42 days.
    Chee W, Sharp CR, Boyd CJ, Claus MA, Smart L.
    J Vet Emerg Crit Care (San Antonio); 2022 Mar; 32(2):189-195. PubMed ID: 34766698
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of the products of cryoprecipitation: RiCoF is deficient in cryosupernatant plasma.
    Freedman M, Rock G.
    Transfus Apher Sci; 2010 Oct; 43(2):179-82. PubMed ID: 20719565
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of prolonged storage on coagulation Factor (F)V, FVII, and FVIII in thawed plasma: is it time to extend the expiration date beyond 5 days?
    Tholpady A, Monson J, Radovancevic R, Klein K, Bracey A.
    Transfusion; 2013 Mar; 53(3):645-50. PubMed ID: 22803679
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of ADAMTS13 and Von Willebrand factor levels and activities, and plasminogen levels, in plasma products currently available for the treatment of thrombotic thrombocytopenic purpura in South Africa.
    van Marle AC, Joubert J, Meiring SM.
    Transfus Apher Sci; 2019 Feb; 58(1):72-78. PubMed ID: 30551950
    [Abstract] [Full Text] [Related]

  • 14. Retention of coagulation factors in plasma frozen after extended holding at 1-6 degrees C.
    Smith JF, Ness PM, Moroff G, Luban NL.
    Vox Sang; 2000 Feb; 78(1):28-30. PubMed ID: 10729808
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.
    Yarranton H, Lawrie AS, Purdy G, Mackie IJ, Machin SJ.
    Transfus Med; 2004 Feb; 14(1):39-44. PubMed ID: 15043592
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.